A B S T R A C T Endocrine function has been investigated in four anencephalic neonates to determine the influence of absence of cortical and hypothalamic tissue and of hypoplasia of the pituitary. Intravenous glucose administration resulted in higher peak values for blood sugar and more rapid glucose disposal rates than reported in normals. Intravenous insulin tolerance tests on two of the infants failed to evoke elevations in plasma growth hormone, and the infants showed a remarkable resistance to the hypoglycemic effect of insulin. Administration of lysine-vasopressin caused an active growth hormone release. Similarly, there was a large increase in serum thyrotropin after administration of synthetic thyrotropinreleasing hormone. Basal levels of both thyrotropin and growth hormone were low as compared with values reported for normal newborns. Prolactin values obtained on three of the infants were in the normal range. The results strongly suggest that anterior pituitary function mediated by the hypothalamus and its releasing factors is deficient in anencephaly. However, the anterior pituitary can release growth hormone and thyrotropin when stimulated directly and, in the case of thyrotropin release, may function autonomously. The normal prolactin values presumably reflect the absence of the hypothalamic prolactin inhibitory factor.
INTRODUCTION
Defects of neural tube formation that include anencephaly and meningocele are the most common major congenital anomalies in the United States (1) . The incidence of these malformations ranges from 1 Received for publication 6 December 1972 and in revised form 2 March 1973. velopment of the neural tube (2) . A major clinical feature of anencephaly is prolonged gestation (3) . Infants with anencephaly are of normal proportions but are generally under the 50th percentile for weight (4) . Pathological studies reveal hypoplastic pituitaries and small adrenals, deficient in a fetal zone (5, 6) . The thyroid, gonads, and the number of pancreatic islets appear to be normal (7) , but P-cell hypertrophy is often seen (8) .
As complete absence of the hypothalamus is a feature of anencephaly (4), these infants offer an opportunity to investigate endocrine function in the absence of an intact hypothalamic-pituitary axis. We will report on endocrine studies in four such anencephalic infants.
METHODS
Four anencephalic infants, three females and a male, were included in the study. Birth (11) . TSH was labeled with "2I (specific activity 50-100 uCi/Ag) by the method of Hunter and Greenwood (12) , and the ['lI]TSH was purified by gel chromatography on Sephadex G-100.
The sensitivity of the method was less than 0.5 ng/ml serum. Under the conditions of this assay 1.0 ng TSH/ml of serum is equivalent to 2 ,uU/ml.
Growth hormone was determined according to the method described by Catt, Niall, and Treager (13) . Plasma cortisol values were determined by the method of Kliman (14) , and radioimmunoassay of serum insulin was measured as described by Soeldner and Slone (15) . Serum thyroxine (T4) was measured by the method of Cassidy, Benotti, and Pino (16) , and free thyroxine was determined by a modification of the method of Sterling and Brenner (17) . Prolactin determinations were kindly performed by Dr. Lawrence Jacobs, Washington University School of Medicine (18) . The radioimmunoassay for prolactin does not cross-react with other pituitary peptides nor with placental lactogen.
RESULTS
Postmortem examination of all the infants revealed acrania and anencephaly. Hypothalamic tissue was not identified grossly nor by microscopic brain sections in any of the infants. The brain stem was fairly well preserved in baby D, but at the mesencephalic-diencephalic junction the neural tube was flattened forming an array of cyst-like structures filled with fluid. Hypoplastic pituitary glands were identified in all subjects, and the combined adrenal glands of each infant weighed less than 1 g (normal 6-8 g). Thyroid architecture was well preserved. Baby C had an absent clitoris, but ovaries and uterus were present. Babies A and B showed large islet cells in the pancreas as previously described by Driscoll, Benirschke, and Curtis (8) . Nuclear chromatin masses were present in the three phenotypic females and absent in the male.
Glucose and insulin tolerance tests. The results of the intravenous glucose tolerance tests of babies A and B are illustrated in Fig. 1 . The glucose peaks observed at 10 and 15 min were higher than observed in normal neonates, and glucose disappearance was more rapid. The Kt values (19) Thyroid status and response to thyrotropin-releasing hormone. The thyroid glands of all infants weighed between 1.8 and 2 g at autopsy; this is within the normal range for newborns. The serum thyroxine (T4) values in all patients were between 10 and 11 ug/100 ml; the concentration of free To varied between 1.8 and 2.2 ng/ 100 ml. TSH values obtained during the first 24 h of life (5-6 ng/ml) were lower than reported by others (20) . The response of three of the infants to synthetic thyrotropin-releasing hormone (TRH) is shown in Fig. 2 . In contrast to the failure of growth hormone release after insulin administration, there was evidence of active secretion of growth hormone after injection of vasopressin. As is also shown in Fig. 2 tisol levels increased to more than 100% of the basal level 30 min after vasopressin administration.
The responsiveness of the adrenals to exogenous AC-TH was also determined in babies C and D. The plasma cortisol concentration increased from basal levels of less than 5 ug to 14 Mg/100 ml (infant C) and 15 g/i100 ml (infant D) 30 min after ACTH infusion.
Prolactin measurements. Serum prolactin levels obtained on three of the infants are shown in Table III . In contrast to the low resting levels of growth hormone and TSH, the prolactin values of these infants indicated an active secretion. Samples obtained from babies B and C during the first 24 h of life were higher than the value obtained on baby D on the 4th day of life. DISCUSSION The role of hypothalamic-releasing factors in controlling hormone secretion from the anterior pituitary is well established (21, 22 (20, 23) ;
however, logistical problems precluded such an evaluation.
Serum growth hormone levels have been reported to be high (30-50 ng/ml) during the first days of life (25, 26) . Resting growth hormone values of the infants reported here were low or negligible, and growth hormone secretion was not stimulated by insulin-induced hypoglycemia. Although there was marked resistance to insulin, babies C and D (Table I) did sustain falls of 20-30 mg/100 ml in blood sugar without showing increases jn serum growth hormone concentration. Such falls in blood sugar have been reported to be sufficient to provoke hormone secretion in normal adults (27) . Cornblath, Parker, Reisner, Forbes, and Daughday (25) have shown insulin-induced hypoglycemia to be a potent stimulus to growth hormone secretion in the normal newborn. By contrast, growth hormone secretion was stimulated in these anencephalic infants after administration of lysine-vasopressin. Vasopressin appears to have a "releasing factor-like" action on anterior pituitary hormone secretion (28, 29) . Kaplan and Grumbach (30) have previously reported the growth hormone concentration of anencephalic pituitaries to be in the low-normal range. The data of the present study indicate that although hypothalamic control of growth hormone secretion is absent in anencephalics, the pituitary can secrete growth hormone in response to specific stimulation. It has been reported (31) that stimulation of growth hormone secretion by insulin-induced hypoglycemia is inhibited if the hypothalamus is maintained normoglycemic. More recently, Himsworth, Carmel, and Frantz (32) provided direct evidence for specific glucose receptors in the lateral hypothalamus. The absence of such centers in alnencephaly would, of course, preclude such a control system. Autoregulation of growth hormone secretion by growth hormone itself, another postulated mechanism for growth hormone control (33, 34) , would also be interfered with if the sensor is in the hypothalamus. (25) . The stability of serum glucose levels shown by these anencephalic infants during fasting and insulin-induced hypoglycemia is of considerable interest but not well understood. Administration of 1 U/kg of insulin (10 times the standard dose) to baby D caused only a 30 mg/100 ml fall in blood sugar. Possible mechanisms for the glucose stability and insulin resistance include an abnormal catechol or insulin response or the secretion of a diabetogenic pituitary factor. Serum catechol and fatty acid levels were not determined in the present investigation. As these studies were carried out within the first 24 h of life it is unlikely that the insulin resistance is related to starvation. It has been suggested, moreover (39), that glucose stability of anencephalic infants is related to decreased glucose utilization because of the absence of central nervous system tissue. Standard intravenous glucose tolerance tests in our subjects showed higher than normal glucose levels at 10-15 min. Also, the glucose disappearance rate (Kt) for the anencephalics was faster than reported for normals (Kt = 1.03) (19) . The results are similar to the Kt of 1.7% a minute reported for an anencephalic infant by Grunt and Reynolds (39). The increased glucose disappearance may relate to the high peak levels achieved; however, we have no satisfactory explanation for this observation. Also, urine glucose losses were not determined. Normal infants show considerable variation in insulin secretion in response to a glucose load. Bowie, Mulligan, and Schwartz (19) suggested that the slow initial rate of glucose clearance in newborns is due to delayed insulin secretion in response to a glucose load. Isles, Dickson, and Farquhar (40) reported that 8 of 10 newborns had an immediate insulin response after glucose administration. However, most of the infants in their study also had a sluggish second insulin peak at 60 min. The delayed insulin response shown by the anencephalic infants (Fig. 1 ) may therefore be normal and not related to the central nervous system pathology.
